13,000 got suspect steroid shots; risk uncertain

October 8, 2012 by Mike Stobbe
A vial of injectable steroids from the New England Compounding Center is displayed in the Tennessee Department of Health in Nashville, Tenn., on Monday, Oct. 8, 2012. The CDC has said an outbreak of fungal meningitis may have been caused by steroids from the Massachusetts specialty pharmacy. (AP Photo/Kristin M. Hall)

(AP)—As many as 13,000 people received steroid shots suspected in a U.S. meningitis outbreak, health officials said Monday. But it's not clear how many are in danger.

Officials don't how many of the shots may have been contaminated with meningitis-causing fungus tied to the outbreak. And the figure includes not only those who got them in the back for pain—who are most at risk—but also those who got the shots in other places, like knees and shoulders.

Those injected in joints are not believed to be at risk for fungal meningitis, said Curtis Allen, a spokesman for the Centers for Disease Control and Prevention. He said there was no breakdown available of how many had the shots in the back or in joints.

The CDC count of cases reached 105 on Monday, including eight deaths. A ninth death was reported late Monday by a Nashville, Tennessee, hospital.

All had received shots for back pain, and investigators suspect a steroid medication made by a specialty pharmacy. About 17,700 single-dose vials of the steroid sent to 23 U.S. states have been recalled. Inspectors found at least one sealed vial contaminated with fungus, and tests were being done on other vials.

The first known case of the rarely seen fungal meningitis was diagnosed last month in Tennessee. The steroid maker, New England Compounding Center of Framingham, Massachusetts, recalled the drug, and over the weekend recalled everything else it makes.

"While there is no indication at this time of any contamination in other NECC products, this recall is being taken as a precautionary measure," the company said in a statement.

Meningitis is an inflammation of the lining of the brain and spinal cord, and a back injection would put any contaminant in more direct contact with that lining.

Symptoms on meningitis include severe headache, nausea, dizziness and fever. The CDC said many of the cases have been mild and some people had strokes. Symptoms have been appearing between one and four weeks after patients got the shots.

A Michigan man whose wife's death was linked to the outbreak said Monday that he, too, was treated with steroids from one of the recalled batches.

"Not only have I lost my wife, but I'm watching the clock to see if anything develops," George Cary said, as friends and family gathered for his wife's wake in Howell, 60 miles (96 kilometers) northwest of Detroit.

His wife, Lilian, 67, had been ill since late August, but meningitis wasn't detected until Sept. 22, her husband said. She suffered a stroke and died Sept. 30, he said.

Fungal meningitis is not contagious like the more common forms. The two types of fungus linked so far to the outbreak are all around, but very rarely causes illness. Fungal meningitis is treated with high-dose antifungal medications, usually given intravenously in a hospital.

The steroid is known as preservative-free methylprednisolone acetate, which the compounding pharmacy creates by combining a powder with a liquid.

Explore further: Steroid-related meningitis cases rise to 105

shares

Related Stories

Steroid-related meningitis cases rise to 105

October 8, 2012
(AP)—Health officials say the number of people sickened by a deadly meningitis outbreak has now reached 105 cases.

Steroid-related meningitis cases rise to 47

October 5, 2012
(AP)—As the tally from a deadly meningitis outbreak rose Friday, health officials identified the medical clinics across the country that received steroid shots for back pain now linked to the illnesses.

US: Avoid drugs from company tied to meningitis (Update)

October 4, 2012
U.S. health officials ramped up warnings Thursday about a specialty pharmacy linked to a widening outbreak of a rare kind of meningitis, urging doctors and hospitals not to use any products from the company.

US clinics rush to warn of tainted steroid; 5 dead

October 5, 2012
(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.

US pharmacy linked to outbreak issues wide recall

October 7, 2012
(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

CDC: More than 90 people ill with meningitis

October 7, 2012
(AP)—Health officials say they have now confirmed more than 90 cases of a rare fungal meningitis that has been linked to a steroid commonly used to ease back pain.

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.